Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress
Clinical Collections
Advances in Alzheimer’s

Keynote webinar | Spotlight on medication adherence

LIVE: Thursday 27th June 2024, 18:00-19:30 (CEST)
Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.
ADVANCED SEARCH
Log in
Top
Journal of General Internal Medicine
Published in: Journal of General Internal Medicine 8/2019

01-08-2019 | Concise Research Reports

How Often Do Systematic Reviews Exclude Articles Not Published in English?

Authors: Jeffrey L. Jackson, MD, MPH, Akira Kuriyama, MD, MPH

Published in: Journal of General Internal Medicine | Issue 8/2019

Login to get access

Excerpt

Systematic reviews are an increasingly important part of the clinical evidence base. Well-conducted reviews provide solid evidence for clinical decision-making, though there are a number of important biases that can impact on the validity of study conclusions. One of the quality markers for systematic reviews is the thoroughness of the search. Our study’s purpose was to assess the frequency that systematic reviews are limited to studies published in English. …
Literature
1.
Gregoire G, Derderian F, Le LJ. Selecting the language of the publications included in a meta-analysis: is there a Tower of Babel bias? J Clin Epidemiol 1995;48(1):159–163.CrossRef
2.
Winkmann G, Schlutius S, Schweim HG. Citation rates of medical German-language journals in English-language papers - do they correlate with the impact factor, and who cites?. Dtsch Med Wochenschr 2002;127(4):138–143.PubMed
3.
Moher D, Fortin P, Jadad AR, et al. Completeness of reporting of trials published in languages other than English: implications for conduct and reporting of systematic reviews. Lancet 1996;347(8998):363–366.CrossRef
4.
Juni P, Holenstein F, Sterne J, Bartlett C, Egger M. Direction and impact of language bias in meta-analyses of controlled trials: empirical study. Int J Epidemiol 2002;31(1):115–123.CrossRef
5.
Hartling L, Featherstone R, Nuspl M, Shave K, Dryden DM, Vandermeer B. Grey literature in systematic reviews: a cross-sectional study of the contribution of non-English reports, unpublished studies and dissertations to the results of meta-analyses in child-relevant reviews. BMC Med Res Methodol 2017;17(1):64.CrossRef
6.
Egger M, Zellweger-Zahner T, Schneider M, Junker C, Lengeler C, Antes G. Language bias in randomised controlled trials published in English and German. Lancet 1997;350(9074):326–329.CrossRef
Metadata
Title
How Often Do Systematic Reviews Exclude Articles Not Published in English?
Authors
Jeffrey L. Jackson, MD, MPH
Akira Kuriyama, MD, MPH
Publication date
01-08-2019
Publisher
Springer US
Published in
Journal of General Internal Medicine / Issue 8/2019
Print ISSN: 0884-8734
Electronic ISSN: 1525-1497
DOI
https://doi.org/10.1007/s11606-019-04976-x

Other articles of this Issue 8/2019

Journal of General Internal Medicine 8/2019 Go to the issue

Clinical Practice: Clinical Vignettes

GABABR-Mediated Paraneoplastic Limbic Encephalitis Due To Thymic Small Cell Carcinoma

Concise Research Reports

Frailty and Acute Kidney Injury: a 1-Year Follow-up of a Prospective Cohort

Perspective

Just a Game: the Dangers of Quantifying Medical Student Professionalism

Letter to the Editor

Physician-Assisted Suicide: Against Medical Neutrality

OriginalPaper

Ten Ways Artificial Intelligence Will Transform Primary Care

Letter to the Editor

Response to Factors Affecting Resident Satisfaction in Continuity Clinic
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Reserve your place

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

Read more

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine
Image Credits